This annual three day event will explore new research into TB detection, treatment and vaccination as well as new developments in controlling and preventing Mycobacterium tuberculosis Infection.
With an informal academic atmosphere and international speakers, it is the perfect environment for debate and discussion.
Deadlines
The Deadline for abstract submissions for oral presentation is 10th March 2016
The early registration deadline is 20th April 2016
The Deadline for abstract submissions for poster presentation is 5th June 2016
Who Should Attend: This event welcomes those working within tuberculosis research and treatment, drug discovery, global health, physicians and those working on novel technologies related to TB detection and control.
THIS EVENT HAS FINISHED
THE FOLLOW UP EVENT IS
Fighting Back Against Infectious Diseases – 5th – 7th September 2017
The 2016 TB Summit has an open abstract session: Abstracts can be submitted on any subject related to Mycobacterium Tuberculosis
Talks Include
Talk Title | Speaker | Affiliation | Country |
---|---|---|---|
Communicating risks and benefits of preventive tuberculosis treatment for shared decision making | Dr. Claudia Dobler | University of New South Wales | Australia |
On the identifiability of transmission dynamic models for infectious diseases | Dr. Jarno Lintusaari | Aalto University | Finland |
Integrated interdisciplinary approaches to tackle extensively drug resistance in TB | Dr Sanjib Bhakta | University of London | United Kingdom |
TB in healthcare workers | Professor Albert Nienhaus | University Medical Center Hamburg-Eppendorf | Germany |
Host defence mechanisms during early stages of tuberculosis in zebrafish | Professor Annemarie H. Meijer | Leiden University | Netherlands |
Intracellular growth of Mycobacterium tuberculosis; linking microbial physiology to drug development. | Dr. Yossef Av-Gay | The University of British Columbia | Canada |
Understanding and intervening in HIV-tuberculosis | Dr. Robert J Wilkinson | University of Cape Town | South Africa |
Tuberculosis therapeutics that inhibit bacterial sensing and resistance to host immunity | Dr. Rob Abramovitch | Michigan State University | United States |
A vaccine pipeline - phage display for biomarker identification and generation of human antibodies for diagnostics and therapy | Dr. Michael Hust | Universität Braunschweig | Germany |
TBC | Dr Amador Goodridge | INDICASAT-AIP | Panama |
Coughing and the transmission of tuberculosis | Dr. Richard Turner | Homerton University Hospital NHS Foundation Trust | United Kingdom |
Extensive Drug Resistant Tuberculosis plus Linezolid Resistance: Linezolid resistance development in Lisbon, Portugal | Isabel Portugal | University of Lisbon | Portugal |
TB persisters - resistance is futile, time to end them all | Dr. Yanmin Hu | St George's University of London | United Kingdom |
Development of Dinitrobenzyl Oxadiazoles and Thiadiazoles as Selective Antitubercular Agents | Dr Jaroslav Roh | Charles University in Prague | Czech Republic |
Design and synthesis of antitubercular small molecules targeting drug-resistant mycobacteria | Dr. Daniele Castagnolo | King's College London | United Kingdom |
Development and deployment of new TB drugs | Dr. Gerry Davies | Liverpool, Liverpool | United Kingdom |
TBC | Dr. Frédéric J. Veyrier | INRS-Institut Armand-Frappier | Canada |
Recent Developments in Childhood Tuberculosis | Dr. James A Seddon | Imperial College London | United Kingdom |
Adjunctive immunotherapy of tuberculosis using vitamin D and phenylbutyrate: a randomized double-blind clinical trial | Dr. Susanna Brighenti | Karolinska Institutet | Sweden |
3 million TB cases missing: can community based services find them? | Professor Luis E. Cuevas | School of Tropical Medicine | United Kingdom |
Assessment of terbium (III) as a probe for the detection of tuberculosis biomarkers | Dr. Thu-Hoa Tran-Thi | Centre national de la recherche scientifique | France |
Capturing Geographic Complexity in a Homeless “Neighborhood”: spatial video geonarratives (SVG) in Skid Row, Los Angeles | Professor Andrew Curtis | Kent State University | United States |
Understanding TB transmission with whole-genome sequencing and modelling | Dr. Caroline Colijn | Imperial College London | United Kingdom |
Improvements in Energetics-Based Methods for Target Identification in TB Drug Discovery | Dr. Cristiano V. Bizarro | Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS | Brazil |
The Mtb Divisome: Initial Structural Efforts on Drug Targets | Dr. Timothy A. Cross | Florida State University | United States |
TBC | Professor Onn Min Kon | Imperial College Healthcare NHS Trust | United Kingdom |
Plant natural products for TB treatment and prophylaxis | Dr. R. S. Santhosh | SASTRA University | India |
Rapid differentiation of Mycobacteria | Dr Linda Stewart | Queen's University | United Kingdom |
TBC | Professor Dirk Schnappinger | Weill Cornell Medical College | United States |
TB or not TB? - Metabolomics may hold the answer | Professor Du Toit Loots | North-West University | South Africa |
TaqMan Array Card for genotypic drug resistance testing | Professor Eric R. Houpt | University of Virginia | United States |
TBC | Dr Dimitrios Evangelopoulos | University College London | United Kingdom |
The role of human gamma/delta T cells in the immunity against the infection of Mycobacterium tuberculosis. | Dr. Baiqing Li | Bengbu Medical College | China |
PURE-TB-LAMP: Simple & Rapid screenging test for TB | Dr Yasuyoshi Mori, Eike | Chemical Co.,Ltd | Japan |
Genomes, structural biology and drug discovery: Understanding antimicrobial resistance in tuberculosis | Professor Tom Blundell | University of Cambridge | United Kingdom |
TBC | Dr. Ill Young Lee | Korea Research Institute of Chemical Technology | South Korea |
Plants a source of antitubercular agents | Dr. Maria del Rayo Camacho-Corona | Universidad Autónoma de Nuevo León | Mexico |
Transcriptional Regulation in Mycobacteria | Dr. Eric Galburt, Washington | University School of Medicine | United States |
Innate immune recognition of pathogenic mycobacteria | Dr. Antje Blumenthal | The University of Queensland Diamantina Institute | Australia |
Toxin:antitoxin modules as regulators of TB growth and persistence | Associate Professor Shaleen Korch | Midwestern University | United States |
"Bring me back to life" - resuscitation of dormant mycobacteria. | Dr. Galina Mukamolova | niversity of Leicester | United Kingdom |
Purinergic signaling in the immune response to severe tuberculosis | Professor Maria Regina D'Imperio Lima | Universidade de São Paulo | Brazil |
IFITM family members restrict Mycobacterium tuberculosis infection | Dr Shahin Ranjbar | Harvard Medical School | United States |
TBC | Dr Prakash Udhawdas Tahiliani | Prime Ever Ayurvedic Research Laboratories | India |
Multiple Biomarkers for Reliable Identification of Mycobacterium Tuberculosis Complex in Broth Culture Media with Nanodiamond | Professor Peng Wen-Ping | National Dong Hwa University | Taiwan |
De novo design of short synthetic membrane-targeting anti-mycobacterial peptides. | Jasmeet Singh Khara | Imperial College London | United Kingdom |
Next Generation Tuberculosis Diagnostics: Test and Treat | Dr. Elisa Tagliani | Emerging Bacterial Pathogens Unit | Italy |
A vaccine pipeline: phage display for identification of vaccine candidates, and generation of human antibodies for diagnostics and therapy | Dr. Gustavo Moreira | Technische Universität Braunschweig | Germany |
Advisory Board Members
Member | Affiliation | Country |
---|---|---|
Dr Tomoshige Matsumoto | Osaka Anti-Tuberculosis Association | Japan |
Professor Edith Sim | University of Oxford | United Kingdom |
Mr Michel Baltas | CNRS | France |
Dr Sandrine Lesellier | Animal and Plant Health Agency (APHA) | United Kingdom |
Professor P K Das | University of Amsterdam | The Netherlands |
CPD Credits
Credits from The Institute of Biomedical Science (code) | Approved by the Royal Society of Biology for purposes of CPD | ||
---|---|---|---|
18(MD026N16) | This event may be counted as 54 CPD credits |
Related Past Agendas
Mycobacterium Tuberculosis Infection Treatment – 26th March 2014
Mycobacterium Tuberculosis Infection Detection – 25th March 2014
Mycobacterium Tuberculosis Infection Prevention – 24th March 2014 Forensic Investigations to locate and identify the missing – 5th March 2014
Contact
Phone:?(+44) 020 3807 3712
Abstract and Poster Presentations
All abstracts accepted for oral presentation are also automatically accepted for poster presentation
INSTRUCTIONS
- How to submit your abstract -www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
- Accepted poster instructions - ?www.lifescienceevents.com/poster-sessions
- Accepted oral presentation instructions - www.lifescienceevents.com/oral-presentations